Dezhan Healthcare Company Limited (SHE:000813)

China · Delayed Price · Currency is CNY

3.480

+0.130 (3.88%)

Aug 20, 2026, 3:04 PM CST

Dezhan Healthcare Company Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	396.16	396.81	466.49	498.09	570.86	734.48
Revenue Growth	-12.84%	-14.94%	-6.35%	-12.75%	-22.28%	-23.72%
Gross Profit	196.55	211.23	296.09	274.96	211.41	473.06
Operating Income	-195.81	-182.03	-80.67	-55.69	-153.1	49.77
Net Income	-357.73	-345.42	-20.41	83.31	-46.95	-57.58
Earnings Per Share	-0.17	-0.16	-0.01	0.04	-0.02	-0.03
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Pharmaceutical Industry	394.03	463.89	489.24	562.19	703.17
Peptides	1.77	2.09	5.88	4.85	7.09
Other	1.01	0.5	0.7	0.23	0.03
Total	396.81	466.49	498.09	570.86	734.48

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	1,416	1,816	2,531	2,796	2,999	2,492
Total Debt	132.91	134.78	18.13	7.57	9.07	12.36
Net Cash (Debt)	1,283	1,681	2,513	2,789	2,990	2,480
Net Cash Growth	-48.75%	-33.10%	-9.91%	-6.73%	20.58%	-29.44%
Net Cash Per Share	0.61	0.79	1.17	1.28	1.35	1.11

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	2.77	4.72	-14.59	127.87	161.72	42.41
Capital Expenditures	-279.13	-235.99	-166.55	-159.73	-67.56	-126.92
Free Cash Flow	-276.37	-231.27	-181.14	-31.86	94.16	-84.51
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	49.61%	53.23%	63.47%	55.20%	37.04%	64.41%
Operating Margin	-49.43%	-45.87%	-17.29%	-11.18%	-26.82%	6.78%
Pretax Margin	-110.00%	-105.95%	-9.46%	16.43%	-21.21%	-5.05%
Profit Margin	-90.30%	-87.05%	-4.38%	16.73%	-8.22%	-7.84%
FCF Margin	-69.76%	-58.28%	-38.83%	-6.40%	16.50%	-11.51%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	84.57	-	-
Forward PE	-	25.96	25.96	25.96	25.96	25.96
P/FCF Ratio	-	-	-	-	87.40	-
PS Ratio	18.42	20.29	14.53	14.15	14.42	12.29